NANOVIRICIDES, INC. Income (Loss) from Continuing Operations, Per Diluted Share
NANOVIRICIDES, INC. (NNVC) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.17 per share for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2017-09-28
- NANOVIRICIDES, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2017-03-31 was -$0.05.
- NANOVIRICIDES, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2016-12-31 was -$0.03.
- NANOVIRICIDES, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2016-09-30 was -$0.05.
- NANOVIRICIDES, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2016-03-31 was -$0.09.
- NANOVIRICIDES, INC. income (loss) from continuing operations, per diluted share for fiscal 2017 was -$0.17.
- NANOVIRICIDES, INC. income (loss) from continuing operations, per diluted share for fiscal 2016 was -$0.19.
- NANOVIRICIDES, INC. income (loss) from continuing operations, per diluted share for fiscal 2015 was -$0.09.
- NANOVIRICIDES, INC. income (loss) from continuing operations, per diluted share for fiscal 2014 was -$0.27.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|
| 2017-06-30 | -$0.17 10-K · filed 2017-09-28 | |||
| 2017-03-31 | -$0.05 10-Q · filed 2017-05-15 | -$0.13 10-Q · filed 2017-05-15 | ||
| 2016-12-31 | -$0.03 10-Q · filed 2017-02-14 | -$0.08 10-Q · filed 2017-02-14 | ||
| 2016-09-30 | -$0.05 10-Q · filed 2016-11-14 | |||
| 2016-06-30 | -$0.19 10-K · filed 2017-09-28 | |||
| 2016-03-31 | -$0.09 10-Q · filed 2017-05-15 | -$0.16 10-Q · filed 2017-05-15 | ||
| 2015-12-31 | -$0.05 10-Q · filed 2017-02-14 | -$0.07 10-Q · filed 2017-02-14 | ||
| 2015-09-30 | -$0.02 10-Q · filed 2016-11-14 | |||
| 2015-06-30 | -$0.09 10-K · filed 2017-09-28 | |||
| 2015-03-31 | -$0.02 10-Q · filed 2016-05-10 | -$0.07 10-Q · filed 2016-05-10 | ||
| 2014-12-31 | -$0.04 10-Q · filed 2016-02-09 | -$0.05 10-Q · filed 2016-02-09 | ||
| 2014-09-30 | $0.02 10-Q · filed 2015-11-09 | |||
| 2014-06-30 | -$0.27 10-K · filed 2016-09-16 | |||
| 2014-03-31 | -$0.02 10-Q · filed 2015-05-15 | -$0.13 10-Q · filed 2015-05-15 | ||
| 2013-12-31 | -$0.03 10-Q · filed 2015-02-25 | -$0.16 10-Q · filed 2015-02-25 | ||
| 2013-06-30 | -$0.19 10-K · filed 2015-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |